At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Canada based CFO’ operating in the Biotechnology space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Neil Klompas
Chief Financial Officer & EVP Business Operations of Zymeworks
Mr. Klompas is Zymeworks’ Chief Financial Officer, and brings over 20 years of healthcare and biotechnology experience to Zymeworks’ management team. Additionally, in conjunction with the CEO, he manages Zymeworks’ corporate growth initiatives including corporate alliances, licensing and partnerships. Prior to joining Zymeworks he worked with KPMG LLP in Canada and the US, most recently with KPMG’s Pharmaceuticals, Biotechnology and Medical Device M&A Transaction Services practice in Princeton NJ, where he advised on numerous transactions including mergers, acquisitions, divestitures and strategic alliances. Prior to that, Mr. Klompas worked with KPMG’s Canadian Biotechnology and Pharmaceuticals practice in the fields of assurance, valuations and taxation. Mr. Klompas is a Chartered Accountant and is a member of the institute of CA’s of British Columbia.
Follow Neil Klompas:
About Zymeworks: Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Michael Singer
Chief Financial Officer of Clementia Pharmaceuticals
Michael Singer is the chief financial officer of [Clementia Pharmaceuticals](https://www.crunchbase.com/organization/clementia-pharmaceuticals), a biopharmaceutical company focused on innovative therapies for people living with rare diseases. He was previously the CFO of Bedrocan Cannabis. Singer holds a bachelor’s degree from Concordia University.
Follow Michael Singer:
About Clementia Pharmaceuticals: Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.
Nizar Bharmal
Chief Financial Officer of Aurin Biotech
Nizar Bharmal is a renowned Certified General Accountant with over 30 years of well-merited accomplishments in his field. He was granted the professional designation of CGA in 1980. Early in his career he worked in the real estate development and investment field. From 1982 until 1985 Mr. Bharmal was Manager of the Bomarc Group, a management company providing services for reporting companies. In 1985, Mr. Bharmal passed the Canadian Securities Course with honors and founded Nizar Bharmal Inc. as a public practice dedicated to providing an array of accounting services, including Canadian and US taxation, financial consulting and corporate management for reporting companies. During his career, he has served as CEO and CFO for several publicly listed companies, where he has gained deep insight into both operations and regulatory affairs. Mr. Bharmal’s extensive association with and commitment to local business communities has resulted in admiration and confidence from many of his colleagues.
Follow Nizar Bharmal:
About ArcPacific Resources, Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Vasco Larcina. CPA
Chief Financial Officer of Lumira Ventures
Contributing over 20 years of senior financial management and audit experience, Vasco is a key member of senior management working closely with our investment team, external auditors and other finance professionals and acting as the primary point of contact for our limited partners. Having worked through the re-organization of the company and the disposition of the retail segment of the business, Vasco now focuses on the growth of the institutional fund management business, the streamlining of finance and legal operations and external reporting to our limited partners. Responsible for the financial management of Lumira Ventures and the investment funds it manages, Vasco oversees financial and legal operations, ensuring that the appropriate controls are in place to manage the activities of Lumira Ventures and its managed funds through the strategic evaluation, development and implementation of financial policies, systems and procedures developed in consideration of external reporting, risk and governance as well as regulatory and tax compliance. Prior to joining Lumira Ventures, Vasco worked as an external auditor with KPMG and has gained internal audit and operational audit experience with a regulated public utility where he provided the internal control input for a major customer information system development project.
Follow Vasco Larcina. CPA:
About Lumira Ventures: Canada’s leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.
Jeff McKinnon
CFO & VP, Operations of TruLeaf
Follow Jeff McKinnon:
About Goodleaf Farms, Goodleaf Farms, TruLeaf: TruLeaf Smart Plant Systems® are an innovative technology that leverages multi-level farming for biomedical and food markets.
Bill Mantzoutsos
Chief Financial Officer & Director of JADE Healthcare Group Inc.
Co-Founder of JADE Healthcare Group.
Follow Bill Mantzoutsos:
About JADE Healthcare Group Inc.: Intelligent Cloud Computed Health Monitoring
Kimberly Stephens
Chief Financial Officer of Appili Therapeutics
Kimberly Stephens joined Appili Therapeutics as Chief Financial Officer in 2016.
Follow Kimberly Stephens:
About Appili Therapeutics: Appili Therapeutics is an anti-infective pharmaceutical development company.
Patrick Montpetit
Partner and Chief Financial Officer of NuChem Sciences
Patrick Montpetit has over fifteen years of experience in senior financial management positions. He is a chartered accountant, specializing in corporate finance and has extensive experience in the life sciences and biopharmaceutical industries. Prior to joining Immunotec, Mr. Montpetit served as Vice-President, Finance and Chief Financial Officer of Bioniche Life Sciences Inc. and Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc. His professional experience includes serving as Chairman of the Quebec Biotechnology Association and Director of the Montreal InVivo organization.
Follow Patrick Montpetit:
About NuChem Sciences: NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal.
Benoit Lorrain
Co-Founder & CFO of Genia Photonics
Benoit Lorrain is Co-Founder & CFO at Genia Photonics.
Follow Benoit Lorrain:
About Genia Photonics: Genia Photonics develops picosecond fiber laser systems for molecular spectroscope systems.
Christopher Hopton
Chief Financial Officer of Sirona Biochem
Christopher Hopton is Sirona Biochem’s Chief Financial Officer. He brings 25 years of expertise in financial management and operations. His extensive experience covers areas of financial planning, accounting policy and business process improvement. As a business investment and finance consultant, Mr. Hopton has worked with several public and privately-held companies. Most recently, Mr. Hopton was the Chief Financial Officer of Central Resources Corp., a junior mineral exploration company. Formerly, he held the position of Division Controller at Canadian Airlines where he was responsible for an annual operating budget of $200M. Mr. Hopton was also involved in the restructuring of 360 Networks, a network communications company, which led to a buyout by Bell Canada. Mr. Hopton earned his Bachelor of Business Administration from Simon Fraser University in British Columbia, Canada and received his professional designation as a Certified General Accountant.
Follow Christopher Hopton:
About Sirona Biochem, Ziptrek: Sirona Biochem is a biotechnology company developing diabetes therapeutics, as well as skin depigmenting and anti-aging agents.
Thomas Kordyback
Chief Financial Officer of RepliCel Life Sciences
Tom Kordyback is a Chartered Accountant and a member of the British Columbia Institute of Chartered Accountants with over 25 years of experience in corporate finance and management for emerging growth companies. From 1984 to 1994, he held senior financial positions with Glenayre Electronics Inc. and Telelink Communications Inc. and worked as a consultant to other Vancouver area companies. In 1995, he began working for Creo, now part of Eastman Kodak Company as their Chief Financial Officer. In this role he oversaw private financings totally over $80 million and in 1999 he led the company’s Initial Public Offering on NASDAQ. He remained at Creo until 2000; at which time, the company had over 4000 employees worldwide. In 2004, Mr. Kordyback joined Extreme CCTV Inc., a developer and manufacturer of state-of-the-art surveillance systems listed on the TSX. He worked for them for three years as a director and member of its Audit, Compensation and Merger and Acquisitions Committees. In 2008 the company was sold to Bosch Security Systems, Inc. for CDN $93 million. Mr. Kordyback currently serves as a director of Silver Sun Resources Corp., a public Canadian-based resource company.
Follow Thomas Kordyback:
About RepliCel Life Sciences: RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
David Long
Chief Financial Officer of BioVectra
David Long is the Chief Financial Officer of BioVectra. He has over 30 years of experience in Finance and IT leadership, including the CDMO space. He obtained an MBA in Finance and International Business from Dalhousie University.
Follow David Long:
About BioVectra: BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
Mark Leung
CFO of Aereus Technologies
Follow Mark Leung:
About Aereus Technologies: Aereus is a pioneer in the global metallic antimicrobial coating industry.
Mark Leung
CFO of Aereus Technologies
Follow Mark Leung:
About Aereus Technologies: Aereus is a pioneer in the global metallic antimicrobial coating industry.
George Dorin
Chief Financial Officer & Corporate Secretary of Pyng Medical
Mr. Dorin has 30 years of broad-based financial experience, including 15 years as a Corporate Director or CFO for several private and public companies. He holds undergraduate degrees in Science and Accounting from the University of BC, a Masters Degree in Finance from the London School of Economics, and the Diploma FCSI (Fellow of the Canadian Securities Institute). A Chartered Accountant, he was also granted a CF (Corporate Finance) specialist designation from the CICA in 2008. Prior to his work in industry, he worked in the financial services sector with Ernst & Whinney (now KPMG), Price Waterhouse, Royal Bank of Canada, and with Pemberton Securities (now RBC Dominion Securities). In 2007 and 2008 he was a Senior VP Corporate Finance at Wolrige Mahon, a BC-based CA Firm. Most recently, he has been providing corporate finance, senior financial management and corporate director (including audit committee chairman) services to several industrial public companies through this own company CANUS Capital Corporation.
Follow George Dorin:
About Pyng Medical: Pyng Medical develops trauma and resuscitation products for the health care industry.
Nelson Isabel
Chief Financial Officer & Senior Vice President, Finance of Highland Therapeutics
Follow Nelson Isabel:
About Highland Therapeutics: Highland Therapeutics is a specialty pharmaceutical company that uses technologies to optimize the delivery of previously approved drugs.
Branko Jankovic
VP & CFO of Ceapro
Follow Branko Jankovic:
About Ceapro: Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.
Randy Baughman
Chief Financial Officer of Kimble Chase Life Science and Research
Prior to joining Kimble Chase, Randy held increasing responsibilities at several multi-national corporations, most recently as CFO of Gerresheimer Glass, Inc. His responsibilities included finance, treasury, tax, and IT. Randy is also responsible for Global Supply Chain activities within Kimble Chase. Prior to Gerresheimer Glass. Inc., Randy was Financial Director for 10 years at Valeo Automotive, including a two year secondment in Sweden. He held functional and business management responsibilities for finance, treasury, tax, and IT at various divisions/locations within Valeo. Earlier in his career, Randy was a Staff Accountant for a local CPA firm, where he went on to earn his CPA certificate. Randy graduated from Penn State University with a BS degree in Accounting, Management and a minor in Economics.
Follow Randy Baughman:
About Kimble Chase Life Science and Research: Kimble Chase Life Science and Research is a leading producer of laboratory and scientific glassware.
Cameron Nelson
CFO of Mati Therapeutics
Cameron Nelson is the CFO at Mati Therapeutics.
Follow Cameron Nelson:
About Mati Therapeutics: Mati Therapeutics offers a delivery system to deliver drugs to the surface of the eye through the tear film.
Cameron Nelson
CFO of Mati Therapeutics
Cameron Nelson is the CFO at Mati Therapeutics.
Follow Cameron Nelson:
About Mati Therapeutics: Mati Therapeutics offers a delivery system to deliver drugs to the surface of the eye through the tear film.
Bruce Colwill
CFO of InMed Pharmaceuticals
Bruce Colwill is the Chief Financial Officer at InMed Pharmaceuticals.
Follow Bruce Colwill:
About InMed Pharmaceuticals: InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
Sylvain Guénette
CFO of Labopharm
Follow Sylvain Guénette:
About Labopharm: Labopharm is an international, specialty pharmaceutical company focused on optimizing the performance of existing drugs.
Bill Adams
Chief Financial Officer of NervGen Pharma
Follow Bill Adams:
About NervGen Pharma: NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.
Sean Bovingdon
CEO and Interim CFO of The Green Organic Dutchman Holdings
Sean Bovingdon is the CEO and Interim CFO at The Green Organic Dutchman Holdings.
Follow Sean Bovingdon:
About The Green Organic Dutchman Holdings: TGOD grows high quality, organic cannabis with sustainable, all-natural principles. TGOD has a funded capacity of 116,000 kg.
Louisa Carter
CFO & Founder of Arctic Apples
Follow Louisa Carter:
About Arctic Apples: Arctic Apples develops safe, high-quality tree fruit cultivars that provide growers, processors, wholesalers, retailers, foodservice.